You haven't searched anything yet.
Neurodegenerative diseases are one of the largest medical challenges of our time. Denali Therapeutics is a biotechnology company dedicated to developing breakthrough therapies for neurodegenerative diseases through our deep commitment to degeneration biology and principles of translational medicine. Denali is founded on the collaboration of leading scientists, industry experts, and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.
We invite you to consider an opportunity with Denali to help achieve our goal of delivering meaningful therapeutics to patients.
Responsibilities:
Provides strategic and technical leadership to large molecule therapeutic discovery projects.
Utilizes SPR / Biacore / Octet and other methods to accurately characterize antibody-target and other protein-protein interaction affinities
Develops and performs additional assays to identify and investigate novel large-molecule therapeutics.
Independently run studies to precisely characterize and quantify antibody-target and other protein-protein interactions and affinities using SPR (Biacore), Octet, ELISA-based, and other relevant assays
Supports efforts to gain structural and mechanistic insights on novel large molecule therapeutics by independently developing and running novel assays to investigate large molecule interactions, affinities, activities, stability, effects on cellular pathways and biomarkers, etc.
Works collaboratively across a wide range of therapeutic discovery, characterization, selection, and optimization programs to support drug discovery efforts
Provides detailed reports that can be used by teams for candidate selection and regulatory filings
Requirements:
BS with 5 years, MS with 3 years or PhD with 0 years of experience in Biophysics, Biochemistry, or a related field
Experience leading antibody:target and protein:protein binding and mechanistic studies is required (e.g. SPR (Biacore), Octet, ELISA).
Experience developing, optimizing, and running protein-protein and cell-based binding and activity assays is desired
Experience generating data / documents suitable for regulatory filings desired
Demonstrated ability to work effectively and collaboratively with other scientists on cross-functional projects teams
Experience working with multiple protein targets, both hands-on and coordinating with CROs and/or academic partners
Excellent oral and written communication skills
Motivated, scientifically driven individual with a creative approach to complex biochemical problem solving
This compensation and benefits information is based on Denali’s good faith estimate as of the date of publication and may be modified in the future.
Denali is committed to its core company value of unity by creating a diverse and inclusive environment. We are proud to be an equal opportunity employer and do not discriminate against any employee or applicant for employment because of race, color, sex, age, national origin, religion, sexual orientation, gender identity and/or expression, status as a veteran, basis of disability, or any other federal, state, or local protected class.
Applicant Privacy Policy
https://www.denalitherapeutics.com/denali-applicant-privacy-policy
Full Time
Ancillary Healthcare
$129k-165k (estimate)
06/19/2024
08/18/2024
denalitherapeutics.com
WAXHAW, NC
200 - 500
2015
Public
$200M - $500M
Ancillary Healthcare
Denali is a California-based biotechnology company that develops and commercializes novel therapies for the treatment of neurodegenerative diseases.